EV Targeting MCF-7 Breast Cancer Cell Lines Inhibit Both mTOR and HIF-1A: Molecular Docking Study. Medico Legal Update, [S. l.], v. 21, n. 1, p. 1367–1373, 2021. DOI: 10.37506/mlu.v21i1.2511. Disponível em: https://ijop.net/index.php/mlu/article/view/2511. Acesso em: 25 may. 2026.